R. Sanders (Sandy) Williams, MD, is a physician-scientist and biomedical executive. He serves currently as Professor of Medicine and Senior Advisor for Science & Technology at Duke University. He is President and CEO Emeritus of the Gladstone Institutes and Professor Emeritus at the University of California San Francisco. Other prior leadership positions include Vice President for Research & Innovation at Duke; Dean of the School of Medicine at Duke; founding Dean of the Duke-NUS Graduate Medical School in Singapore; and Chief of Cardiology at the University of Texas Southwestern Medical Center. He was educated at Princeton University and Duke School of Medicine, and he pursued advanced training at Harvard (residency at Massachusetts General Hospital), Duke (cardiology and biochemistry fellowships), Oxford University (molecular biology), and Cold Spring Harbor Laboratory (molecular biology). He is active at the interface between academia and biomedical industries, including service as a Director of public companies Bristol-Myers Squibb, Amgen, Laboratory Corporation of America, and Tenaya Therapeutics. Dr. Williams is an elected member of the U.S. National Academy of Medicine.